Newbridge Financial Services Group, Inc. Precision Biosciences Inc Transaction History

Newbridge Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$2.96 - $7.76 $0 - $0	0 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$7.4 - $11.66 $203,130 - $320,067	-27,450 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$9.18 - $14.15 $6,885 - $10,612	-750 Reduced 2.66%	27,450 $317,000
Q2 2021 Sep 07, 2021	SELL	$8.07 - $12.52 $95,629 - $148,362	-11,850 Reduced 29.59%	28,200 $353,000
Q1 2021 Sep 07, 2021	BUY	$8.57 - $15.79 $336,801 - $620,547	39,300 Added 5240.0%	40,050 $415,000
Q4 2020 Sep 07, 2021	BUY	$5.98 - $12.47 $4,485 - $9,352	750 New	750 $6,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $842M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.